Inclusion of pregnant and lactating women in TB treatment and vaccine trials
S-A. Meehan, A.C. Hesseling, L. Viljoen, L.M. Cranmer, S. Verkuijl, K. Viney, M. Maktabi, M. Isaacs, Y. Hirsch-Moverman · 2026
Read Inclusion of pregnant and lactating women in TB treatment and vaccine trials by S-A. Meehan, A.C. Hesseling, L. Viljoen, L.M. Cranmer, S. Verkuijl, K. Viney, M. Maktabi, M. Isaacs, Y. Hirsch-Moverman (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13577204.txt.
Description
Meehan and co-authors ask why pregnant and nursing women are left out of tuberculosis trials in this 2026 paper. For years, trials of TB drugs and vaccines shut them out by default. That denial blocks their access to new treatments and prevention.
The team listed recent, current, and planned TB trials and checked their entry rules. They also interviewed trial leaders and sponsors at depth. Of 40 treatment trials, only seven included these women. Three more let women stay if they became pregnant mid-trial. The paper maps the barriers and what might lift them.
Catalog record
| CREATOR | S-A. Meehan, A.C. Hesseling, L. Viljoen, L.M. Cranmer, S. Verkuijl, K. Viney, M. Maktabi, M. Isaacs, Y. Hirsch-Moverman |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |